Pluri Inc. (PLUR): Gross Profit
$453.0K
Year ended 2026-06-30
+17.7%
3-year compound annual growth
-16.5%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $453.0K | -30.7% | 2026-09-10, From 2025-07-01 |
| 2025-06-30 | $654.0K | +103.1% | 2026-09-10, From 2024-07-01 |
| 2024-06-30 | $322.0K | +15.8% | 2025-09-17, From 2023-07-01 |
| 2023-06-30 | $278.0K | +18.8% | 2024-09-18, From 2022-07-01 |
| 2022-06-30 | $234.0K | n/a | 2023-09-12, From 2021-07-01 |
| No annual figure between 2020-06-30 and 2022-06-30. | |||
| 2020-06-30 | $23.0K | -55.8% | 2021-09-13, From 2019-07-01 |
| 2019-06-30 | $52.0K | +8.3% | 2020-09-10, From 2018-07-01 |
| 2018-06-30 | $48.0K | n/a | 2020-09-10, From 2017-07-01 |
| No annual figure between 2016-06-30 and 2018-06-30. | |||
| 2016-06-30 | $2.75M | +650.5% | 2018-09-12, From 2015-07-01 |
| 2015-06-30 | $366.0K | -0.5% | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | $368.0K | -44.2% | 2016-09-07, From 2013-07-01 |
| 2013-06-30 | $659.0K | -5.2% | 2015-09-09, From 2012-07-01 |
| 2012-06-30 | $695.0K | n/a | 2014-09-11, From 2011-07-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Pluri Inc. (PLUR) | 2026-06-30 | $453.0K | -30.7% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | -$2.65M | n/m |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | $57.2K | n/a |
| Humacyte, Inc. (HUMA) | 2025-12-31 | -$7.66M | n/a |
| Dyadic International Inc (DYAI) | 2025-12-31 | $770.5K | -66.5% |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | $4.27M | +13.0% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $9.62M | n/a |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | $12.81M | n/a |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | $0 | -100.0% |
Compare PLUR, SCNI, OTLK, HUMA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗